Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation

American Journal of Transplantation

Volumn 10, Issue 2, 2010, Pages 398-406

  Neidlinger, N ^a   Singh, N ^a   Klein, C ^a   Odorico, J ^a   Munoz Del Rio, A ^a   Becker, Y ^a   Sollinger, H ^a   Pirsch, J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cytomegalovirus (CMV); Cytomegalovirus infection; Pancreas transplant; Pancreas transplantation; Posttransplant diabetes; Posttransplant diabetes mellitus

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; DEXAMETHASONE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORAL ANTIDIABETIC AGENT; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL; VALGANCICLOVIR;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CYTOMEGALOVIRUS; DIABETES MELLITUS; DIET RESTRICTION; DRUG MEGADOSE; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PANCREAS TRANSPLANTATION; POSTTRANSPLANT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

BODY MASS INDEX; DIABETES MELLITUS; INCIDENCE; INSULIN; MULTIVARIATE ANALYSIS; PANCREAS TRANSPLANTATION; RISK FACTORS; TISSUE DONORS; WEIGHT GAIN;

EID: 75149139832     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02935.x     Document Type: Article

References (52)

1. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967 61 : 827 837.
2. CDC. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes in the United States. Department of Health and Human Services, Centers for Disease Control and Prevention, 1998.
3. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999 67 : 645 648.
4. Robertson RP, Sutherland DE, Lanz KJ. Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation. Diabetes 1999 48 : 1737 1740.
5. Jones JW Jr., Mizrahi SS, Bentley FR. Type II diabetes after combined kidney and pancreas transplantation for type I diabetes mellitus and end-stage renal disease. Clin Transplant 1996 10 : 574 575.
6. Smith JL, Hunsicker LG, Yuh WT, Wright FH Jr., Van Voorhis L, Corry RJ. Appearance of type II diabetes mellitus in type I diabetic recipients of pancreas allografts. Transplantation 1989 47 : 304 311.
7. Wadstrom J, Gannedahl G, Wahlberg J, Frodin L, Tedbrandt A, Berne C. Development of type II diabetes after combined kidney-pancreas transplantation in a patient with type I (insulin-dependent) diabetes. Transplant Proc 1994 26 : 1761 1762.
8. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003 75 (10 Suppl SS3 SS24.
9. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002 25 : 583 592.
10. Pham PT, Pham PC, Lipshutz GS, Wilkinson AH. New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 2007 36 : 873 890 vii.
11. Jindal RM. Posttransplant diabetes mellitus-a review. Transplantation 1994 58 : 1289 1298.
12. Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997 16 : 242 257.
13. Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999 34 : 1 13.
14. Battezzati A, Benedini S, Caldara R et al. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001 71 : 1560 1565.
15. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant 2008 8 : 175 182.
16. Pfeffer F, Nauck MA, Drognitz O, Benz S, von Dobschuetz E, Hopt UT. Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation. Transplantation 2003 76 : 1427 1431.
17. Davidson JA, Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: An endocrinologist's view. Diabetes Care 2004 27 : 805 812.
18. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008 31 (Suppl 1 S55 S60.
19. Porrini E, Moreno JM, Osuna A et al. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: A prospective and multicenter study. Transplantation 2008 85 : 1133 1138.
20. Vincenti F, Friman S, Scheuermann E et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007 7 : 1506 1514.
21. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008 93 : 2447 2453.
22. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009 32 : 1327 1334.
23. Drachenberg CB, Papadimitriou JC, Klassen DK et al. Evaluation of pancreas transplant needle biopsy: Reproducibility and revision of histologic grading system. Transplantation 1997 63 : 1579 1586.
24. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005 19 : 291 298.
25. Snapinn S, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 2005 59 : 292 300.
26. Team RdC. R : A Language environment for statistical computing. Vienna, Austria : R foundation for statistical computing, 2008.
27. Depczynski B, Daly B, Campbell LV, Chisholm DJ, Keogh A. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med 2000 17 : 15 19.
28. Hjelmesaeth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997 64 : 979 983.
29. Midtvedt K, Hjelmesaeth J, Hartmann A et al. Insulin resistance after renal transplantation: The effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004 15 : 3233 3239.
30. Troppmann C. Nonimmunologic endocrine graft dysfunction. In : Gruessner RW, Sutherland DE, eds. Transplantation of the pancreas. New York : Springer-Verlag, 2004 : 249 252.
31. Cho YM, Park KS, Jung HS et al. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care 2003 26 : 1123 1128.
32. Hur K, Sim S, Kim Y, Kang E, Nam J, KIm S. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 2007 30 : 609 615.
33. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3 : 178 185.
34. Colditz GA, Willett WC, Stampfer MJ et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990 132 : 501 513.
35. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000 106 : 473 481.
36. Krieger NR, Odorico JS, Heisey DM et al. Underutilization of pancreas donors. Transplantation 2003 75 : 1271 1276.
37. Sutherland DE, Gruessner RW, Dunn DL et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001 233 : 463 501.
38. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 2007 7 (5 Pt 2 1359 1375.
39. Stegall MD, Dean PG, Sung R et al. The rationale for the new deceased donor pancreas allocation schema. Transplantation 2007 83 : 1156 1161.
40. Legendre C, Pascual M. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: Late-onset disease and indirect consequences. Clin Infect Dis 2008 46 : 732 740.
41. Sagedal S, Nordal KP, Hartmann A et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation 2000 70 : 1166 1174.
42. Hjelmesaeth J, Sagedal S, Hartmann A et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004 47 : 1550 1556.
43. Ducloux D, Kazory A, Simula-Faivre D, Chalopin JM. One-year post-transplant weight gain is a risk factor for graft loss. Am J Transplant 2005 5 : 2922 2928.
44. el-Agroudy AE, Wafa EW, Gheith OE, Shehab el-Dein AB, Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 2004 77 : 1381 1385.
45. Kang ES, Kim MS, Kim YS et al. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients. Diabetes 2008 57 : 1043 1047.
46. van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2004 19 (Suppl 6 vi8 vi12.
47. Ostenson CG. The pathophysiology of type 2 diabetes mellitus: An overview. Acta Physiol Scand 2001 171 : 241 247.
48. Delgado P, Diaz JM, Silva I et al. Unmasking glucose metabolism alterations in stable renal transplant recipients: A multicenter study. Clin J Am Soc Nephrol 2008 3 : 808 813.
49. McLaughlin T, Reaven G, Abbasi F et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005 96 : 399 404.
50. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Lancet 1994 344 : 423 428.
51. Woodward RS, Schnitzler MA, Baty J et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003 3 : 590 598.
52. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002 359 : 248 252.